Physician profile
Laurie E Gossard
NPI 1639285117
$10,474.10
in general payments reported to CMS, 2019-2025
60 companies · $1,924 in 2025
The $1,924 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $531 · 2021: $678 · 2022: $1,985 · 2023: $2,013 · 2024: $2,433 · 2025: $1,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,370.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,393.41 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,280.90 | 2019-2025 | |
| Pfizer INC. | $843.54 | 2019-2025 | |
| Lilly USA, LLC | $754.04 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $502.89 | 2019-2025 | Evenity, Prolia, Otezla |
| Janssen Pharmaceuticals, INC | $487.80 | 2019-2024 | Xarelto |
| Abbott Laboratories | $482.95 | 2020-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $453.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $345.10 | 2019-2025 | Airsupra, Farxiga |
| Sanofi-Aventis U.S. LLC | $324.76 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $317.90 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.54 | 2019-2025 | Jardiance, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $236.31 | 2022-2024 | |
| Exact Sciences Corporation | $227.87 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $219.37 | 2023-2024 | Korlym |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Gossard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.